Itsuko Furuta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Itsuko Furuta has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Takahiro Yamada
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
9 shared publicationsMamoru Morikawa
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
8 shared publicationsSatoshi Ishikawa
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
8 shared publications- Tianyue Zhai
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
8 shared publications Hisanori Minakami
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
7 shared publicationsKinuko Nakagawa
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
5 shared publications
Latest Publications
- 17 August 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (11) , 1700-1707
Perinatal mortality in Japanese women diagnosed with gestational diabetes mellitus and diabetes mellitus
Aims: The objective of this study was to determine how many pregnant Japanese women with diabetes mellitus (DM)/gestational diabetes mellitus (GDM) experience perinatal mortality in the presence of fetal anomalies.Methods: Our investigation included data from 205 secondary/tertiary obstetric facilities located widely in Japan. The Japan Ministry of Health, Labour and Welfare Vital Statistics of Japan was used for comparison.Results: Of 237 941 women giving birth at 205 hospitals, 1796 (0.8%) and 13 037 (5.5%) had DM and GDM, respectively. The perinatal mortality rates (per 1000 births) were 10.6 (19/1796) for women with DM, 5.2 (68/13037) for women with GDM, and 3.7 (7612/2039504) for the general Japanese population. Detailed information was available for 63 (72%) of the 87 perinatal deaths occurring in women with diabetes including DM and GDM; fetal anomalies were associated with 40% (25/63) of perinatal deaths, exceeding 16% (1211/7612) in the general Japanese population (P < 0.0001). The leading four fetal anomalies associated with perinatal mortality in women with diabetes were fetal trisomy (6 cases: 1 of trisomy‐13 and 5 of trisomy‐18), non‐immune hydrops fetalis (5 cases), cardiac deformities (3 cases) and holoprosencephaly (2 cases).Conclusions: Perinatal mortality was more likely to occur in women with glucose intolerance. In the Japanese infants that succumbed to perinatal mortality, fetal anomaly was more prevalent in those born to women with a glucose intolerance than in those born to the general population.
- 17 August 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (11) , 1700-1707
Perinatal mortality in Japanese women diagnosed with gestational diabetes mellitus and diabetes mellitus
Aims: The objective of this study was to determine how many pregnant Japanese women with diabetes mellitus (DM)/gestational diabetes mellitus (GDM) experience perinatal mortality in the presence of fetal anomalies.Methods: Our investigation included data from 205 secondary/tertiary obstetric facilities located widely in Japan. The Japan Ministry of Health, Labour and Welfare Vital Statistics of Japan was used for comparison.Results: Of 237 941 women giving birth at 205 hospitals, 1796 (0.8%) and 13 037 (5.5%) had DM and GDM, respectively. The perinatal mortality rates (per 1000 births) were 10.6 (19/1796) for women with DM, 5.2 (68/13037) for women with GDM, and 3.7 (7612/2039504) for the general Japanese population. Detailed information was available for 63 (72%) of the 87 perinatal deaths occurring in women with diabetes including DM and GDM; fetal anomalies were associated with 40% (25/63) of perinatal deaths, exceeding 16% (1211/7612) in the general Japanese population (P < 0.0001). The leading four fetal anomalies associated with perinatal mortality in women with diabetes were fetal trisomy (6 cases: 1 of trisomy‐13 and 5 of trisomy‐18), non‐immune hydrops fetalis (5 cases), cardiac deformities (3 cases) and holoprosencephaly (2 cases).Conclusions: Perinatal mortality was more likely to occur in women with glucose intolerance. In the Japanese infants that succumbed to perinatal mortality, fetal anomaly was more prevalent in those born to women with a glucose intolerance than in those born to the general population.
- 16 June 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 1008-1013
Post‐partum podocyturia following pre‐eclamptic pregnancy
Aim: Urine podocin mRNA expression and urine podocin : nephrin mRNA expression ratio (PNR) increase with increasing proteinuria during pregnancy complicated with pre‐eclampsia (PE). This suggests that urine podocytes with reduced nephrin mRNA expression are abundant in pathological podocyturia. The aim of this study was therefore to determine post‐partum changes in podocyturia and PNR in relation to proteinuria after pre‐eclampsia (PE).Methods: A total of 137 peripartum urine specimens, consisting of 72 and 65 from 24 and 30 women with PE and normotensive control pregnancies (NCP), respectively, were studied. Determination of urine protein and creatinine concentration and quantitative analysis of podocyte‐specific podocin and nephrin mRNA expression were carried out using reverse transcription–polymerase chain reaction in pelleted urine samples. Podocyturia was monitored via urine podocin mRNA expression. Podocyturia and proteinuria were normalized by urine creatinine concentration.Results: Podocyturia and urine PNR decreased with decreasing proteinuria as well as with increasing time after delivery in the urine from PE women. In physiological proteinuria (i.e. protein : creatinine ratio [P/Cr] 0.005–0.1 mg/mg), however, both podocyturia and PNR were significantly greater in the urine from PE women compared with NPC women, although P/Cr was similar between the groups (median, 0.037 mg/mg for PE vs 0.029 mg/mg for NCP).Conclusions: Podocyturia decreases with decreasing proteinuria in PE women after childbirth. In PE women, however, pathological podocyturia consisting of podocytes with decreased nephrin mRNA expression persisted even after proteinuria decreased to a level similar to that in NCP women.
- 16 June 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 1008-1013
Post‐partum podocyturia following pre‐eclamptic pregnancy
Aim: Urine podocin mRNA expression and urine podocin : nephrin mRNA expression ratio (PNR) increase with increasing proteinuria during pregnancy complicated with pre‐eclampsia (PE). This suggests that urine podocytes with reduced nephrin mRNA expression are abundant in pathological podocyturia. The aim of this study was therefore to determine post‐partum changes in podocyturia and PNR in relation to proteinuria after pre‐eclampsia (PE).Methods: A total of 137 peripartum urine specimens, consisting of 72 and 65 from 24 and 30 women with PE and normotensive control pregnancies (NCP), respectively, were studied. Determination of urine protein and creatinine concentration and quantitative analysis of podocyte‐specific podocin and nephrin mRNA expression were carried out using reverse transcription–polymerase chain reaction in pelleted urine samples. Podocyturia was monitored via urine podocin mRNA expression. Podocyturia and proteinuria were normalized by urine creatinine concentration.Results: Podocyturia and urine PNR decreased with decreasing proteinuria as well as with increasing time after delivery in the urine from PE women. In physiological proteinuria (i.e. protein : creatinine ratio [P/Cr] 0.005–0.1 mg/mg), however, both podocyturia and PNR were significantly greater in the urine from PE women compared with NPC women, although P/Cr was similar between the groups (median, 0.037 mg/mg for PE vs 0.029 mg/mg for NCP).Conclusions: Podocyturia decreases with decreasing proteinuria in PE women after childbirth. In PE women, however, pathological podocyturia consisting of podocytes with decreased nephrin mRNA expression persisted even after proteinuria decreased to a level similar to that in NCP women.
- 1 June 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 312 (6) , F1112-F1119
Effects of childbirth on podocyturia in women with normotensive, uncomplicated pregnancies
Changes in hemodynamics and blood pressure occur shortly before and after childbirth regardless of the mode of delivery. This study aimed to test the hypothesis that parturition induces a temporal increase in podocyturia monitored by podocyte-specific protein podocin mRNA expression levels (Pod-mRNA). A total of 105 urine specimens, consisting of 43 and 62 from 18 and 20 otherwise healthy women with vaginal delivery (VD) and elective cesarean delivery (ECS), respectively, were studied. Determination of urine protein and creatinine (Cr) concentrations and quantitative analyses of Pod-mRNA, nephrin mRNA (Nep-mRNA), synaptopodin mRNA (Syn-mRNA), and aquaporin 2 mRNA expression were performed using RT-PCR in pelleted urine samples. Levels of mRNA expression were corrected by urine Cr concentration. Podocyturia increased significantly, concomitant with a significantly decreased Nep:Pod-mRNA ratio (NPR) in the urine, collected immediately before or after childbirth regardless of the delivery mode compared with urine collected before commencement of labor or on postpartum day 3 or later. Podocyturia was significantly negatively correlated with NPR [correlation coefficient (r) = −0.614/−0.750 for VD/ECS women, respectively], as well as the Syn:Pod-mRNA ratio. Systolic blood pressure exceeded 140 mmHg during labor in 50% of VD women, and mean arterial pressure was significantly positively correlated with podocyturia during labor in VD women (r = 0.733). Thus parturition induces a transient increase in urine podocytes with reduced Nep- and Syn-mRNA expressions. Glomerular podocytes with reduced Nep- and Syn-mRNA levels were suggested to be likely to detach from the glomerular basement membrane around childbirth.
- 1 June 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 312 (6) , F1112-F1119
Effects of childbirth on podocyturia in women with normotensive, uncomplicated pregnancies
Changes in hemodynamics and blood pressure occur shortly before and after childbirth regardless of the mode of delivery. This study aimed to test the hypothesis that parturition induces a temporal increase in podocyturia monitored by podocyte-specific protein podocin mRNA expression levels (Pod-mRNA). A total of 105 urine specimens, consisting of 43 and 62 from 18 and 20 otherwise healthy women with vaginal delivery (VD) and elective cesarean delivery (ECS), respectively, were studied. Determination of urine protein and creatinine (Cr) concentrations and quantitative analyses of Pod-mRNA, nephrin mRNA (Nep-mRNA), synaptopodin mRNA (Syn-mRNA), and aquaporin 2 mRNA expression were performed using RT-PCR in pelleted urine samples. Levels of mRNA expression were corrected by urine Cr concentration. Podocyturia increased significantly, concomitant with a significantly decreased Nep:Pod-mRNA ratio (NPR) in the urine, collected immediately before or after childbirth regardless of the delivery mode compared with urine collected before commencement of labor or on postpartum day 3 or later. Podocyturia was significantly negatively correlated with NPR [correlation coefficient (r) = −0.614/−0.750 for VD/ECS women, respectively], as well as the Syn:Pod-mRNA ratio. Systolic blood pressure exceeded 140 mmHg during labor in 50% of VD women, and mean arterial pressure was significantly positively correlated with podocyturia during labor in VD women (r = 0.733). Thus parturition induces a transient increase in urine podocytes with reduced Nep- and Syn-mRNA expressions. Glomerular podocytes with reduced Nep- and Syn-mRNA levels were suggested to be likely to detach from the glomerular basement membrane around childbirth.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 967-973
Effect of urine creatinine level during pregnancy on dipstick test
Aim: Dipstick results for proteinuria are affected by urine concentration, and thus urine creatinine concentration ([Cr]). This study was performed to determine whether spot urine [Cr] changes significantly during pregnancy, leading to a significantly different false‐negative rate (FNR) on dipstick test between trimester.Methods: The [Cr] and protein concentrations ([P]) were analyzed in 631 spot urine samples with negative/equivocal dipstick from 425 pregnant women. False‐negative dipstick was defined as [P] : [Cr] ratio (P/Cr) > 0.27 mg/mg.Results: Median [Cr] was 117 mg/dL (range, 6.5–326 mg/dL), 72 mg/dL (range, 4.3–477 mg/dL), and 73 mg/dL (range, 8.4–396 mg/dL) in the first (n = 96), second (n = 344), and third (n = 191) trimester urine samples, respectively (P = 0.000, Kruskal–Wallis). Both [P] and P/Cr increased significantly with advancing gestation. FNR 9.4% (18/191) in the third trimester was significantly higher than that of 0.0% (0/96) in the second trimester and that of 0.5% (2/344) in the third trimester. In the 20 urine samples with false‐negative dipstick, median [Cr] was 47.0 mg/dL (range, 11.0–358 mg/dL) and the proportion of samples with dilute urine, that is, [Cr] P = 0.046).Conclusions: Urine samples in the second and third trimesters were more likely to be diluted compared with the first trimester. This was associated with high FNR in third trimester urine samples.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 967-973
Effect of urine creatinine level during pregnancy on dipstick test
Aim: Dipstick results for proteinuria are affected by urine concentration, and thus urine creatinine concentration ([Cr]). This study was performed to determine whether spot urine [Cr] changes significantly during pregnancy, leading to a significantly different false‐negative rate (FNR) on dipstick test between trimester.Methods: The [Cr] and protein concentrations ([P]) were analyzed in 631 spot urine samples with negative/equivocal dipstick from 425 pregnant women. False‐negative dipstick was defined as [P] : [Cr] ratio (P/Cr) > 0.27 mg/mg.Results: Median [Cr] was 117 mg/dL (range, 6.5–326 mg/dL), 72 mg/dL (range, 4.3–477 mg/dL), and 73 mg/dL (range, 8.4–396 mg/dL) in the first (n = 96), second (n = 344), and third (n = 191) trimester urine samples, respectively (P = 0.000, Kruskal–Wallis). Both [P] and P/Cr increased significantly with advancing gestation. FNR 9.4% (18/191) in the third trimester was significantly higher than that of 0.0% (0/96) in the second trimester and that of 0.5% (2/344) in the third trimester. In the 20 urine samples with false‐negative dipstick, median [Cr] was 47.0 mg/dL (range, 11.0–358 mg/dL) and the proportion of samples with dilute urine, that is, [Cr] P = 0.046).Conclusions: Urine samples in the second and third trimesters were more likely to be diluted compared with the first trimester. This was associated with high FNR in third trimester urine samples.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (7) , 1152-1158
Serum placental growth factor and soluble fms‐like tyrosine kinase 1 at mid‐gestation in healthy women: Association with small‐for‐gestational‐age neonates
Aim: This study was performed to determine the associations between serum placental growth factor (PlGF) and soluble fms‐like tyrosine kinase 1 (sFlt‐1) levels at mid‐gestation with the risk of small‐for‐gestational‐age (SGA) neonates born at gestational week (GW) ≥ 36 in healthy women.Methods: PlGF and sFlt‐1 concentrations were determined at GW 24–27 in 183 women with births at GW ≥ 36, but without gestational diabetes mellitus and hypertension.Results: Thirteen (7.1%) SGA neonates were born. Median (range) GW at blood sampling was similar between women with and without SGA (25 [24–25] and 24 [24–27], respectively, P = 0.671). Pre‐pregnancy body mass index (BMI) and PlGF levels were significantly lower in women with than without SGA, while sFlt‐1 levels and sFlt‐1 : PlGF ratio (sFlt‐1/PlGF) did not differ significantly between the two groups. PlGF and sFlt‐1/PlGF, but not BMI or sFlt‐1, showed significant correlations with birthweight z‐score; the correlation was positive for PlGF and negative for sFlt‐1/PlGF. Women with PlGF level < 10th percentile and those with sFlt‐1/PlGF level > 90th percentile showed significantly increased risk of SGA compared to those with respective counterpart characteristics; relative risk was 3.8 (95% confidence interval, 1.3–11.3; 21% [4/19] vs 5.5% [9/164]) for PlGF and 7.9 (95% confidence interval, 3.0–20.8, 33.3% [6/18] vs 4.2% [7/165]) for sFlt‐1/PlGF.Conclusion: Maternal PlGF and sFlt‐1/PlGF determined during GW 24–27 were associated with the risk of SGA neonates born at GW ≥ 36, even in women with uncomplicated pregnancies.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (7) , 1152-1158
Serum placental growth factor and soluble fms‐like tyrosine kinase 1 at mid‐gestation in healthy women: Association with small‐for‐gestational‐age neonates
Aim: This study was performed to determine the associations between serum placental growth factor (PlGF) and soluble fms‐like tyrosine kinase 1 (sFlt‐1) levels at mid‐gestation with the risk of small‐for‐gestational‐age (SGA) neonates born at gestational week (GW) ≥ 36 in healthy women.Methods: PlGF and sFlt‐1 concentrations were determined at GW 24–27 in 183 women with births at GW ≥ 36, but without gestational diabetes mellitus and hypertension.Results: Thirteen (7.1%) SGA neonates were born. Median (range) GW at blood sampling was similar between women with and without SGA (25 [24–25] and 24 [24–27], respectively, P = 0.671). Pre‐pregnancy body mass index (BMI) and PlGF levels were significantly lower in women with than without SGA, while sFlt‐1 levels and sFlt‐1 : PlGF ratio (sFlt‐1/PlGF) did not differ significantly between the two groups. PlGF and sFlt‐1/PlGF, but not BMI or sFlt‐1, showed significant correlations with birthweight z‐score; the correlation was positive for PlGF and negative for sFlt‐1/PlGF. Women with PlGF level < 10th percentile and those with sFlt‐1/PlGF level > 90th percentile showed significantly increased risk of SGA compared to those with respective counterpart characteristics; relative risk was 3.8 (95% confidence interval, 1.3–11.3; 21% [4/19] vs 5.5% [9/164]) for PlGF and 7.9 (95% confidence interval, 3.0–20.8, 33.3% [6/18] vs 4.2% [7/165]) for sFlt‐1/PlGF.Conclusion: Maternal PlGF and sFlt‐1/PlGF determined during GW 24–27 were associated with the risk of SGA neonates born at GW ≥ 36, even in women with uncomplicated pregnancies.
- 11 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 873-879
Increased podocyturia in pregnant women compared to non‐pregnant women
Aim: Hyperfiltration is a cause of podocyturia and occurs physiologically in the kidney of pregnant women. Podocyturia is increased in preeclamptic pregnancies, but it is unclear whether there is also any increase in uncomplicated pregnancies. This study was performed to examine whether podocyturia and urine aquaporin 2 mRNA expression are increased in healthy pregnant women (PW) compared to healthy non‐pregnant women (NPW).Methods: Eleven urines obtained from 11 NPW and longitudinal 76 urines from 40 PW with uncomplicated pregnancies (median number [range] of urine samples/person, 2 [1 – 3]) were studied. Determination of protein and creatinine concentrations and number of cells in urine other than blood cells, and quantitative analyses of the mRNA expression of aquaporin 2 (AQP2‐mRNA), podocin (Pod‐mRNA), and nephrin (Nep‐mRNA) were performed using RT‐PCR in pelleted urine samples. Podocyturia was monitored with urine Pod‐ and Nep‐mRNA expression levels normalized relative to creatinine.Results: Urine cell density and urine AQP2‐, Pod‐, and Nep‐mRNA expression normalized relative to creatinine were significantly higher in PW than NPW. The number of cells per milligram of creatinine was significantly positively correlated with expression of all three mRNAs with correlation coefficients (R‐value) of 0.442, 0.481, and 0.561 for Pod‐, Nep‐, and AQP2‐mRNA, respectively. AQP2‐mRNA expression was strongly (R > 0.8) positively correlated with both Pod‐ and Nep‐mRNA expression.Conclusion: Podocyturia monitored by Pod‐ and Nep‐mRNA expression and urine cells expressing AQP2‐mRNA were increased in uncomplicated pregnancies compared to healthy non‐pregnant women. Urine cells expressing AQP2‐mRNA increased with increasing podocyturia in healthy women.
- 11 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 873-879
Increased podocyturia in pregnant women compared to non‐pregnant women
Aim: Hyperfiltration is a cause of podocyturia and occurs physiologically in the kidney of pregnant women. Podocyturia is increased in preeclamptic pregnancies, but it is unclear whether there is also any increase in uncomplicated pregnancies. This study was performed to examine whether podocyturia and urine aquaporin 2 mRNA expression are increased in healthy pregnant women (PW) compared to healthy non‐pregnant women (NPW).Methods: Eleven urines obtained from 11 NPW and longitudinal 76 urines from 40 PW with uncomplicated pregnancies (median number [range] of urine samples/person, 2 [1 – 3]) were studied. Determination of protein and creatinine concentrations and number of cells in urine other than blood cells, and quantitative analyses of the mRNA expression of aquaporin 2 (AQP2‐mRNA), podocin (Pod‐mRNA), and nephrin (Nep‐mRNA) were performed using RT‐PCR in pelleted urine samples. Podocyturia was monitored with urine Pod‐ and Nep‐mRNA expression levels normalized relative to creatinine.Results: Urine cell density and urine AQP2‐, Pod‐, and Nep‐mRNA expression normalized relative to creatinine were significantly higher in PW than NPW. The number of cells per milligram of creatinine was significantly positively correlated with expression of all three mRNAs with correlation coefficients (R‐value) of 0.442, 0.481, and 0.561 for Pod‐, Nep‐, and AQP2‐mRNA, respectively. AQP2‐mRNA expression was strongly (R > 0.8) positively correlated with both Pod‐ and Nep‐mRNA expression.Conclusion: Podocyturia monitored by Pod‐ and Nep‐mRNA expression and urine cells expressing AQP2‐mRNA were increased in uncomplicated pregnancies compared to healthy non‐pregnant women. Urine cells expressing AQP2‐mRNA increased with increasing podocyturia in healthy women.
- Open Access
- 22 November 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 37442
Second-trimester urine nephrin:creatinine ratio versus soluble fms-like tyrosine kinase-1:placental growth factor ratio for prediction of preeclampsia among asymptomatic women
This prospective observational study compare urine nephrin:creatinine ratio (NCR, ng/mg) with serum soluble fms-like tyrosine kinase-1:placental growth factor ratio (FPR, pg/pg) for preeclampsia (PE) prediction among unselected asymptomatic pregnant women in 2nd trimester. NCR and FPR were determined in 254 paired urine/blood samples collected simultaneously from 254 women at median gestational week (GW) 24 (range, 22–27) without hypertension or significant proteinuria in pregnancy (SPIP). Fifteen (5.9%) developed SPIP and hypertension at GW 34.0 (26.0–38.6) and 35.3 (27.6–38.6), respectively, and were diagnosed with PE at GW 35.7 (27.6–38.6). The 90th percentile level determined in 239 women normotensive throughout pregnancy gave NCR (139) sensitivity and positive predictive values (PPV) of 60% (9/15) and 27% (9/33), while those for serum FPR (4.85) were 40% (6/15) and 20% (6/30), respectively. Relative risks (95%CI) of later PE were 10.0 (3.82–26.4; 27% [9/33] vs. 2.7% [6/221]) and 4.98 (1.91–13.0; 20% [6/30] vs. 4.0% [9/224]) for NCR-positive and FPR-positive women, respectively. Cut-offs suggested by ROC gave NCR (86.6) sensitivity and PPV of 87% (13/15) and 17% (13/79), and FPR (8.8) values of 40% (6/15) and 40% (6/15), respectively. Thus, 2nd trimester NCR was superior to FPR for PE prediction.
- 22 November 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 37442
Open AccessSecond-trimester urine nephrin:creatinine ratio versus soluble fms-like tyrosine kinase-1:placental growth factor ratio for prediction of preeclampsia among asymptomatic women
This prospective observational study compare urine nephrin:creatinine ratio (NCR, ng/mg) with serum soluble fms-like tyrosine kinase-1:placental growth factor ratio (FPR, pg/pg) for preeclampsia (PE) prediction among unselected asymptomatic pregnant women in 2nd trimester. NCR and FPR were determined in 254 paired urine/blood samples collected simultaneously from 254 women at median gestational week (GW) 24 (range, 22–27) without hypertension or significant proteinuria in pregnancy (SPIP). Fifteen (5.9%) developed SPIP and hypertension at GW 34.0 (26.0–38.6) and 35.3 (27.6–38.6), respectively, and were diagnosed with PE at GW 35.7 (27.6–38.6). The 90th percentile level determined in 239 women normotensive throughout pregnancy gave NCR (139) sensitivity and positive predictive values (PPV) of 60% (9/15) and 27% (9/33), while those for serum FPR (4.85) were 40% (6/15) and 20% (6/30), respectively. Relative risks (95%CI) of later PE were 10.0 (3.82–26.4; 27% [9/33] vs. 2.7% [6/221]) and 4.98 (1.91–13.0; 20% [6/30] vs. 4.0% [9/224]) for NCR-positive and FPR-positive women, respectively. Cut-offs suggested by ROC gave NCR (86.6) sensitivity and PPV of 87% (13/15) and 17% (13/79), and FPR (8.8) values of 40% (6/15) and 40% (6/15), respectively. Thus, 2nd trimester NCR was superior to FPR for PE prediction.
- 12 November 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (1) , 34-41
Association between nephrinuria, podocyturia, and proteinuria in women with pre‐eclampsia
Aim: Podocyte depletion in the kidney is associated with end‐stage kidney disease (ESKD). Pre‐eclampsia (PE) increases the risk of ESKD in later life. This study was performed to determine whether nephrinuria (soluble nephrin in the urine) is correlated with proteinuria and/or podocyturia (podocytes in the urine) in PE women.Methods: Eighty‐three urine samples, consisting of 45 and 38 samples from 27 normotensive and nine PE women, respectively, underwent simultaneous determination of nephrin, protein, and creatinine concentrations in the urine supernatant and quantitative analysis of podocyte‐specific protein mRNA expression. This included podocin (Pod‐mRNA) and nephrin (Nep‐mRNA), using real‐time polymerase chain reaction in the pelleted urine. Nephrinuria and proteinuria were corrected by creatinine concentration. Pod‐ and Nep‐mRNA expression levels were corrected by GAPDH.Results: Nephrinuria, proteinuria, Pod‐mRNA expression, and Nep‐mRNA expression all increased with advancing gestation in PE women, while not in normotensive women. The nephrinuria was strongly correlated with proteinuria (R = 0.901, P < 0.001), Pod‐mRNA expression level (R = 0.824, P < 0.001), and Nep‐mRNA expression level (R = 0.724, P < 0.001) in urine samples from PE women, while the nephrinuria was significantly correlated with proteinuria alone (R = 0.419, P < 0.005) in urine samples from normotensive women.Conclusion: Nephrinuria reflected well the degrees of proteinuria and podocyturia in PE women. This suggested that increased nephrinuria/proteinuria was associated with podocyte loss in the kidneys of PE women.
- 12 November 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (1) , 34-41
Association between nephrinuria, podocyturia, and proteinuria in women with pre‐eclampsia
Aim: Podocyte depletion in the kidney is associated with end‐stage kidney disease (ESKD). Pre‐eclampsia (PE) increases the risk of ESKD in later life. This study was performed to determine whether nephrinuria (soluble nephrin in the urine) is correlated with proteinuria and/or podocyturia (podocytes in the urine) in PE women.Methods: Eighty‐three urine samples, consisting of 45 and 38 samples from 27 normotensive and nine PE women, respectively, underwent simultaneous determination of nephrin, protein, and creatinine concentrations in the urine supernatant and quantitative analysis of podocyte‐specific protein mRNA expression. This included podocin (Pod‐mRNA) and nephrin (Nep‐mRNA), using real‐time polymerase chain reaction in the pelleted urine. Nephrinuria and proteinuria were corrected by creatinine concentration. Pod‐ and Nep‐mRNA expression levels were corrected by GAPDH.Results: Nephrinuria, proteinuria, Pod‐mRNA expression, and Nep‐mRNA expression all increased with advancing gestation in PE women, while not in normotensive women. The nephrinuria was strongly correlated with proteinuria (R = 0.901, P < 0.001), Pod‐mRNA expression level (R = 0.824, P < 0.001), and Nep‐mRNA expression level (R = 0.724, P < 0.001) in urine samples from PE women, while the nephrinuria was significantly correlated with proteinuria alone (R = 0.419, P < 0.005) in urine samples from normotensive women.Conclusion: Nephrinuria reflected well the degrees of proteinuria and podocyturia in PE women. This suggested that increased nephrinuria/proteinuria was associated with podocyte loss in the kidneys of PE women.
- Open Access
Feasibility of nephrinuria as a screening tool for the risk of pre-eclampsia: prospective observational study
Objectives To investigate the possibility of nephrinuria as a screening tool for the risk of pre-eclampsia (PE). Design Prospective observational study. Setting A single university hospital. Changes in urinary nephrin:creatinine ratio (NCR, ng/mg) and protein:creatinine ratio (PCR, mg/mg) in pregnancy were determined. Significant proteinuria in pregnancy (SPIP) was defined as PCR>0.27. PE was diagnosed in women with both SPIP and hypertension. Participants 89 pregnant women in whom neither hypertension nor SPIP was present at enrolment, providing 31, 125 and 93 random urine samples during first, second and third trimesters, respectively. Results PE developed in 14 of the 89 women. NCR increased with increasing PCR in 14 women with PE (correlation coefficient, 0.862; p122 (95th centile value for 75 women with normotensive pregnancies) was 5.93 (95% CI 2.59 to 13.6; 60% (6/10) vs 10% (8/79)) and 13.5 (95% CI 3.31 to 55.0; 75% (6/8) vs 5.5% (2/36)), respectively, compared with women with NCR≤122 at that time. Conclusions Nephrinuria was unlikely to increase in normal pregnancy. A certain NCR cut-off may efficiently differentiate women at higher risk of PE.
Open AccessFeasibility of nephrinuria as a screening tool for the risk of pre-eclampsia: prospective observational study
Objectives To investigate the possibility of nephrinuria as a screening tool for the risk of pre-eclampsia (PE). Design Prospective observational study. Setting A single university hospital. Changes in urinary nephrin:creatinine ratio (NCR, ng/mg) and protein:creatinine ratio (PCR, mg/mg) in pregnancy were determined. Significant proteinuria in pregnancy (SPIP) was defined as PCR>0.27. PE was diagnosed in women with both SPIP and hypertension. Participants 89 pregnant women in whom neither hypertension nor SPIP was present at enrolment, providing 31, 125 and 93 random urine samples during first, second and third trimesters, respectively. Results PE developed in 14 of the 89 women. NCR increased with increasing PCR in 14 women with PE (correlation coefficient, 0.862; p122 (95th centile value for 75 women with normotensive pregnancies) was 5.93 (95% CI 2.59 to 13.6; 60% (6/10) vs 10% (8/79)) and 13.5 (95% CI 3.31 to 55.0; 75% (6/8) vs 5.5% (2/36)), respectively, compared with women with NCR≤122 at that time. Conclusions Nephrinuria was unlikely to increase in normal pregnancy. A certain NCR cut-off may efficiently differentiate women at higher risk of PE.